Crohn's Disease and Colitis Trial, Recruiting (NCT03915262)

Crohn's Disease and Colitis Trial, Recruiting NCT03915262 Sponsor: Hospices Civils de Lyon Condition: Crohn's Disease and Colitis

Printed from Voxsanity (voxsanity.com.au) — NCT03915262 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Crohns Disease And Colitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years old or older
You have been diagnosed with Crohn's disease for more than 3 months
Your Crohn's disease is currently active, meaning your symptom score is above a certain level AND at least one test (a blood inflammation marker, a stool test, an endoscopy, or an MRI scan) also shows signs of active disease (confirm with trial site)
Your doctor has recommended that you start a biological medication, specifically an anti-TNF, vedolizumab, or ustekinumab

Who may not be able to join:

Your Crohn's disease does not meet the activity level described above
You have had a large section of your small intestine removed (more than 40 cm)
You were diagnosed with chronic pancreatitis (long-term inflammation of the pancreas) before joining the trial
You have a medical reason why you cannot take the biological medications used in this trial
You are currently taking pancreatic enzyme replacement tablets or supplements
You are pregnant or breastfeeding
You are legally under the care of a court-appointed guardian (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Gilles BOSCHETTI, Hospices Civils de Lyon

Phone: 478860302

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT03915262

Sponsor: Hospices Civils de Lyon

Phase: Not Applicable

Status: Recruiting

Condition: Crohn's Disease and Colitis

Trial contact: 478860302

More information: https://clinicaltrials.gov/study/NCT03915262

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years old or older
You have been diagnosed with Crohn's disease for more than 3 months
Your Crohn's disease is currently active, meaning your symptom score is above a certain level AND at least one test (a blood inflammation marker, a stool test, an endoscopy, or an MRI scan) also shows signs of active disease (confirm with trial site)
Your doctor has recommended that you start a biological medication, specifically an anti-TNF, vedolizumab, or ustekinumab

Who may not be able to join:

Your Crohn's disease does not meet the activity level described above
You have had a large section of your small intestine removed (more than 40 cm)
You were diagnosed with chronic pancreatitis (long-term inflammation of the pancreas) before joining the trial
You have a medical reason why you cannot take the biological medications used in this trial
You are currently taking pancreatic enzyme replacement tablets or supplements
You are pregnant or breastfeeding
You are legally under the care of a court-appointed guardian (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Hospices Civils de Lyon

Registry

ClinicalTrials.gov

Start date

15 November 2019

Est. completion

15 November 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Exocrine pancreatic insufficiency's prevalence; Exocrine pancreatic insufficiency's prevalence

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov